Vaxcyte, Inc. (FRA:5VA)
Germany
· Delayed Price · Currency is EUR 37.60
-1.20 (-3.09%)
At close: Dec 5, 2025
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of €5.23 billion as of December 5, 2025. Its market cap has decreased by -48.97% in one year.
Market Cap
5.23B
Enterprise Value
3.83B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€37.60
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from 1.22B to 5.23B, an increase of 327.06%. That is a compound annual growth rate of 30.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 5.23B | -46.93% |
| Dec 31, 2024 | 9.85B | 82.29% |
| Dec 29, 2023 | 5.41B | 52.56% |
| Dec 30, 2022 | 3.54B | 220.92% |
| Dec 31, 2021 | 1.10B | -0.22% |
| Dec 31, 2020 | 1.11B | -9.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.18B |
| Siemens Aktiengesellschaft | 179.36B |
| Allianz SE | 139.47B |
| Deutsche Telekom AG | 130.38B |
| Siemens Energy AG | 99.98B |
| Rheinmetall AG | 70.66B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.26B |
| Deutsche Bank Aktiengesellschaft | 59.33B |